Bharat Immunologicals & Biologicals Corporation Limited

Bharat Immunologicals & Biologicals Corporation Limitedverified

BIBCL.BO

Price:

$18.89

Market Cap:

$815.54M

Bharat Immunologicals & Biologicals Corp. Ltd. is a biotechnology company, which engages in the manufacturing and producing pharmaceutical products such as oral polio vaccines; zinc tablet and diarrhea management kit; and ready to use therapeutic food. It operates through the following business segments: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. The company was founded on March 10, 1989 and is headquartered in Bulandshahr, India.

Industry

Medical - Pharmaceuticals

IPO Date

Stock Exchange

BSE

Ticker

BIBCL.BO

The Enterprise Value as of December 2025 (TTM) for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) is 1.50B

According to Bharat Immunologicals & Biologicals Corporation Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 1.50B. This represents a change of 75.96% compared to the average of 855.28M of the last 4 quarters.

Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) Historical Enterprise Value (quarterly & annually)

How has BIBCL.BO Enterprise Value performed in the past?

The mean historical Enterprise Value of Bharat Immunologicals & Biologicals Corporation Limited over the last ten years is 1.08B. The current 1.50B Enterprise Value has changed 13.81% with respect to the historical average. Over the past ten years (40 quarters), BIBCL.BO's Enterprise Value was at its highest in in the December 2021 quarter at 3.16B. The Enterprise Value was at its lowest in in the December 2013 quarter at 0.

Quarterly (TTM)
Annual

Average

1.08B

Median

930.73M

Minimum

130.16M

Maximum

2.23B

Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bharat Immunologicals & Biologicals Corporation Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 807.14%

Maximum Annual Enterprise Value = 2.23B

Minimum Annual Increase = -62.05%

Minimum Annual Enterprise Value = 130.16M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20231.65B-15.33%
20221.95B-12.56%
20212.23B718.62%
2020271.84M-62.05%
2019716.26M-15.03%
2018842.99M-13.40%
2017973.39M9.61%
2016888.06M-24.79%
20151.18B807.14%
2014130.16M-1.59%

Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) Average Enterprise Value

How has BIBCL.BO Enterprise Value performed in the past?

The current Enterprise Value of Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

1.94B

5-year avg

1.36B

10-year avg

1.08B

Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) Enterprise Value vs. Peers

How is BIBCL.BO’s Enterprise Value compared to its peers?

Bharat Immunologicals & Biologicals Corporation Limited’s Enterprise Value is greater than Welcure Drugs & Pharmaceuticals Limited (1.29B), greater than Source Natural Foods and Herbal Supplements Limited (849.97M), greater than Makers Laboratories Limited (785.86M), greater than Sunil Healthcare Limited (1.32B), greater than Kretto Syscon Limited (548.65M), less than Transchem Limited (1.90B), greater than Jeevan Scientific Technology Limited (984.08M), greater than Mercury Laboratories Limited (1.00B), greater than Raaj Medisafe India Limited (1.41B), greater than Concord Drugs Limited (1.02B),

Build a custom stock screener for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bharat Immunologicals & Biologicals Corporation Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bharat Immunologicals & Biologicals Corporation Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Bharat Immunologicals & Biologicals Corporation Limited's Enterprise Value?

What is the highest Enterprise Value for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)?

What is the 3-year average Enterprise Value for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)?

What is the 5-year average Enterprise Value for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO)?

How does the current Enterprise Value for Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO) compare to its historical average?